Emerging from the UK, retatrutide, a new peptide , is generating considerable excitement within the scientific community regarding its potential for weight management . This dual GIP and GLP-1 receptor agonist appears to provide a considerable improvement over current therapies, showing promising results in initial clinical studies . Researchers th